Yubin Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yubin Chen has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Dawei Zhang
Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Guangzhou Medical University , No. 63 Yayun South Road , Guangzhou , 510000, Guangdong Province , China
1 shared publicationHeping Peng
Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Guangzhou Medical University , No. 63 Yayun South Road , Guangzhou , 510000, Guangdong Province , China
1 shared publicationLiangqi Cao
Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Guangzhou Medical University , No. 63 Yayun South Road , Guangzhou , 510000, Guangdong Province , China
1 shared publicationNa Wang
Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Guangzhou Medical University , No. 63 Yayun South Road , Guangzhou , 510000, Guangdong Province , China
1 shared publicationPing Xue
Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Guangzhou Medical University , No. 63 Yayun South Road , Guangzhou , 510000, Guangdong Province , China
1 shared publication
Latest Publications
- Open Access
- 15 August 2022
- Published by Walter de Gruyter GmbH in Open Life Sciences
- Vol. 17 (1) , 944-951
Long non-coding RNA HOXB-AS1 is a prognostic marker and promotes hepatocellular carcinoma cells’ proliferation and invasion
Long non-coding RNAs (lncRNAs) are broadly transcribed in the genome of human and play critical roles in the progression of multiple diseases. Long non-coding HOXB cluster antisense RNA 1 (HOXB-AS1) is a tumor exciter in various cancers. This study aimed to investigate the involvement of HOXB-AS1 in hepatocellular carcinoma (HCC). In the following study, HOXB-AS1 was unveiled to be highly expressed in HCC tissues as opposed to normal tissues. Silencing of HOXB-AS1 led to the loss of proliferation, migration, and invasiveness of HCC cells, namely Hep3B and Huh7. Moreover, the data showed that expression levels of HOXB-AS1 contribute significantly to the patient’s survival rates. Otherwise, HOXB-AS1 levels in the serum of patients proved HOXB-AS1 as a biomarker for analysis and treatment of HCC. In summary, this study highlights HOXB-AS1 as key upregulated lncRNA in HCC which being an oncogene can cause proliferation and metastasis of HCC cells. The results also highlighted HOXB-AS1 as a promising biomarker for early diagnosis and prognosis of patients with HCC.
- 15 August 2022
- Published by Walter de Gruyter GmbH in Open Life Sciences
- Vol. 17 (1) , 944-951
Open AccessLong non-coding RNA HOXB-AS1 is a prognostic marker and promotes hepatocellular carcinoma cells’ proliferation and invasion
Long non-coding RNAs (lncRNAs) are broadly transcribed in the genome of human and play critical roles in the progression of multiple diseases. Long non-coding HOXB cluster antisense RNA 1 (HOXB-AS1) is a tumor exciter in various cancers. This study aimed to investigate the involvement of HOXB-AS1 in hepatocellular carcinoma (HCC). In the following study, HOXB-AS1 was unveiled to be highly expressed in HCC tissues as opposed to normal tissues. Silencing of HOXB-AS1 led to the loss of proliferation, migration, and invasiveness of HCC cells, namely Hep3B and Huh7. Moreover, the data showed that expression levels of HOXB-AS1 contribute significantly to the patient’s survival rates. Otherwise, HOXB-AS1 levels in the serum of patients proved HOXB-AS1 as a biomarker for analysis and treatment of HCC. In summary, this study highlights HOXB-AS1 as key upregulated lncRNA in HCC which being an oncogene can cause proliferation and metastasis of HCC cells. The results also highlighted HOXB-AS1 as a promising biomarker for early diagnosis and prognosis of patients with HCC.